Legend Biotech Corp Increase Decrease Through Exercise Of Options
Legend Biotech Corp (LEGN) reported Increase Decrease Through Exercise Of Options of $3.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2026-03-10
- Legend Biotech Corp increase decrease through exercise of options for the quarter ending 2025-12-31 was $311.00K, a 54.40% decline year-over-year.
- Legend Biotech Corp increase decrease through exercise of options for the quarter ending 2025-09-30 was $1.27M, a 76.50% decline year-over-year.
- Legend Biotech Corp increase decrease through exercise of options for the quarter ending 2025-06-30 was $273.00K, a 85.88% decline year-over-year.
- Legend Biotech Corp increase decrease through exercise of options for the quarter ending 2025-03-31 was $1.44M, a 18.46% decline year-over-year.
| Period end | Increase Decrease Through Exercise Of Options 3 month | Increase Decrease Through Exercise Of Options 6 month | Increase Decrease Through Exercise Of Options 9 month | Increase Decrease Through Exercise Of Options 12 month | Increase Decrease Through Exercise Of Options 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $311.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $1.58M derived: sum of 2 quarters · filed 2026-03-10 | $1.86M derived: sum of 3 quarters · filed 2026-03-10 | $3.30M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $1.27M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $1.54M derived: sum of 2 quarters · filed 2025-11-12 | $2.99M 6-K · filed 2025-11-12 | $3.67M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | $273.00K derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $1.72M 6-K · filed 2025-08-11 | $2.40M derived: sum of 3 quarters · filed 2026-03-10 | $7.81M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | $1.44M 6-K · filed 2025-05-13 | $2.13M derived: sum of 2 quarters · filed 2026-03-10 | $7.54M derived: sum of 3 quarters · filed 2026-03-10 | $9.47M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | $682.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $6.09M derived: sum of 2 quarters · filed 2026-03-10 | $8.03M derived: sum of 3 quarters · filed 2026-03-10 | $9.80M 20-F · filed 2026-03-10 | $9.72M 20-F · filed 2025-03-11 |
| 2024-09-30 | $5.41M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $7.35M derived: sum of 2 quarters · filed 2025-11-12 | $9.12M 6-K · filed 2025-11-12 | $9.72M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | $1.93M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $3.71M 6-K · filed 2025-08-11 | $4.31M derived: sum of 3 quarters · filed 2026-03-10 | $6.99M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | $1.77M 6-K · filed 2025-05-13 | $2.38M derived: sum of 2 quarters · filed 2026-03-10 | $5.05M derived: sum of 3 quarters · filed 2026-03-10 | $13.20M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | $605.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $3.28M derived: sum of 2 quarters · filed 2026-03-10 | $11.43M derived: sum of 3 quarters · filed 2026-03-10 | $11.80M 20-F · filed 2026-03-10 | $11.82M 20-F · filed 2024-03-19 |
| 2023-09-30 | $2.68M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $10.82M derived: sum of 2 quarters · filed 2024-11-12 | $11.20M 6-K · filed 2024-11-12 | $11.82M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $8.15M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $8.52M 6-K · filed 2024-08-09 | $9.14M derived: sum of 3 quarters · filed 2025-03-11 | $9.70M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $370.00K 6-K · filed 2024-05-13 | $994.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.55M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | $624.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $1.18M derived: sum of 2 quarters · filed 2025-03-11 | $2.93M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | $555.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $2.31M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $1.75M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $4.64M 20-F · filed 2024-03-19 | ||||
| 2021-06-30 | $2.51M 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | $1.46M 20-F · filed 2023-03-30 |